Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow's Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma IndustryBusiness Wire • 08/10/21
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, SwitzerlandBusiness Wire • 08/03/21
Bristol Myers' Opdivo Scores European Approval As Adjuvant Treatment For Gastric CancerBenzinga • 07/30/21
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following ChemoradiotherapyBusiness Wire • 07/30/21
Bristol Myers Squibb (BMY) CEO Giovanni Caforio on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/28/21
Bristol Myers Q2 Earnings Slightly Ahead Of Estimates, Trims FY21 GAAP EPS GuidanceBenzinga • 07/28/21
Bristol Myers swings to profit to beat second-quarter estimates as Opdivo returns to growthMarket Watch • 07/28/21